Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
about
HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progressionInternational Retrovirology Association brings together scientists and clinicians to bridge discoveries about human T-lymphotropic viruses from the laboratory to clinical trials.HTLV-1 p30II: selective repressor of gene expression12th International Conference on Human Retrovirology: HTLV and Related RetrovirusesThe Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesisModulation of DNA damage and repair pathways by human tumour virusesHuman T-cell leukemia virus I tax protein sensitizes p53-mutant cells to DNA damage.HTLV-1-associated adult T cell leukemia is highly susceptible to Navitoclax due to enhanced Bax expression.Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II sensitizes Jurkat T cells to Ras-mediated apoptosisHTLV-I tax increases genetic instability by inducing DNA double strand breaks during DNA replication and switching repair to NHEJ.Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity.The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growthEffect of phosphonated carbocyclic 2'-oxa-3'-aza-nucleoside on human T-cell leukemia virus type 1 infection in vitro.Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alphaHuman T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA repair.Prophylactic cancer vaccination by targeting functional non-selfHuman T-cell leukemia virus type 1 Tax protein down-regulates pre-T-cell receptor alpha gene transcription in human immature thymocytesNuclear export and expression of human T-cell leukemia virus type 1 tax/rex mRNA are RxRE/Rex dependent.Adult T cell leukemia lymphoma.Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12(I) protein of human T-cell leukemia/lymphoma virus type 1.Human T cell lymphotropic virus-associated leukemia/lymphomaPathogenesis and treatment of human T-cell leukemia virus infection.Transcriptional and post-transcriptional gene regulation of HTLV-1.Activation of NF-kappaB by HTLV-I and implications for cell transformation.Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.Inhibition of methyltransferases results in induction of g2/m checkpoint and programmed cell death in human T-lymphotropic virus type 1-transformed cells.HTLV-I Tax-Mediated Inactivation of Cell Cycle Checkpoints and DNA Repair Pathways Contribute to Cellular Transformation: "A Random Mutagenesis Model"Inhibition of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro by carbohydrate-binding agents.Effect of treatment of Strongyloides infection on HTLV-1 expression in a patient with adult T-cell leukemiaHTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking.Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1.Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viabilityNF-κB as a target for oncogenic viruses.Suppression of human T-cell leukemia virus I gene expression by pokeweed antiviral protein.Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator.Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase.Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesisRetired self-proteins as vaccine targets for primary immunoprevention of adult-onset cancers.The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.
P2860
Q24307735-BA8E67D6-2A4D-4947-B19B-C446B2A0E916Q24796407-EE2920B7-4600-4EE7-AA08-0945A1E50423Q24798269-58ED28F4-FD7A-40D2-A31C-825EFA571E9EQ24815699-14CE960B-B32E-4193-BCBF-5D42ED9E3946Q26800055-93BD86E2-9BBB-4C97-A93A-B215F1295363Q26825783-0E45CDE9-2E41-4F98-9E3F-D00BBB6708F0Q30446360-7A0C1D65-DA02-4D19-ABEB-F0CC01E0479CQ33425096-5617562C-8CD3-45D7-B1BE-DA589EC677D3Q33908852-2CD96978-CEE1-4F85-810D-D314BA9EBFD4Q34390827-13F709CA-D286-4573-8551-D9CC91411BACQ34545731-E68A852B-E2A7-44A5-B9CF-C2FEF09A5F49Q34605818-FC5BF818-4B04-4B6B-90C4-792478906AE8Q34675040-D8774927-FF46-4C23-AB79-15F0180865FAQ34707606-83A60C08-132D-4B72-9BE4-A68D81C42A51Q34975323-5002CF35-EF2E-41BC-A5A0-1A9F31AF5B88Q35037411-6D3044B2-DF18-426D-AEA0-47B6F33C7D1AQ35467512-1C7646B8-D795-485D-9696-02D8F8FA36ACQ35634291-F1F0B6FB-D29E-4032-AA38-3E22C6183CABQ35868006-89FA27E0-3320-4C87-BC96-3A9CAF5EEEE3Q35880693-426AD46E-0081-4998-AFB4-0C9E57E95BA5Q35947986-64F9D64C-4DB8-456E-9CEA-16E4299F409AQ36225607-637B61CC-F711-4D80-A8D9-05FFEDF4F85DQ36232724-D95426CD-9BE4-4E5D-B485-4A4349361D94Q36254862-1825B3E0-9CDD-4D8D-9474-CCBC26686959Q36254865-8BD1E261-912B-4B8C-A75B-49ADAAC4553FQ36254880-D0217C10-8CFE-485B-90BB-B87063A96FD7Q36424037-70F1A2C4-4122-4617-ADF9-EAC71FC20964Q36509597-1B9BCB67-A42E-4F69-BB0D-ED23AF9E23BBQ36804058-44809382-63ED-43D1-A5E4-EBE487C4FAEEQ37120722-4F51C2C7-D3E3-4E95-885F-A638FD8F3567Q37152235-6A1D8380-DDFE-4BB6-93BF-E1186ECFBF0AQ37156338-7C17D63A-1803-41D5-B053-0FB05EBDD1B1Q37169145-6CC10C9E-3168-47FE-89CE-91D200F11C20Q37374081-66194179-C26A-4B9B-BBF0-0510F9B76671Q37431569-9A47B91A-2C36-4B3E-B636-6456BDC72BDDQ37568028-3EEFA659-1FF1-4AA8-BC72-0C8A846802C9Q37713530-A87F3F8B-4D08-4673-8A74-54E822491BCBQ38068180-E7CCB5C1-B799-41A2-9AF0-465E922B71AEQ38244698-C191D22F-B92F-4225-9511-9F53CCA4E10CQ39062948-F585B4C1-65C9-418B-A8C9-1B44AB075C1E
P2860
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
@ast
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
@en
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
@nl
type
label
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
@ast
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
@en
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
@nl
prefLabel
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
@ast
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
@en
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
@nl
P2093
P1476
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.
@en
P2093
Christophe Nicot
Genoveffa Franchini
Julie M Johnson
P304
P356
10.1016/S0065-230X(03)01003-0
P577
2003-01-01T00:00:00Z